GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
---|
GLO1 | 4323 | LTM | Triple Negative Breast Cancer | Carcinoma | MDA-MB-157 | NA | Western Blotting followed by SFA | NA | 0.28 | 0.0042 | 30559934
|
MET | 7029 | LTM | Triple Negative Breast Cancer | Carcinoma | MDA-MB-157 | NA | Western Blotting | NA | 0.28 | 0.0191 | 28966724
|
ALDH1A1 | 402 | LTM | Triple Negative Breast Cancer | Carcinoma | MDA-MB-157 | NA | ALDEFLUOR assay followed by SFA | NA | 0.12 | 0.684 | 34848450
|
ALDH1A1 | 402 | LTM | Triple Negative Breast Cancer | Carcinoma | MDA-MB-157 | NA | ALDEFLUOR assay followed by SFA | NA | 0.12 | 0.684 | 28966724
|
ALDH1A1 | 402 | LTM | Triple Negative Breast Cancer | Carcinoma | MDA-MB-157 | NA | ALDEFLUOR assay followed by SFA | NA | 0.12 | 0.684 | 30559934
|